Exacerbation of recalcitrant cutaneous sarcoidosis with adalimumab - a paradoxical effect? A case report

Detalhes bibliográficos
Autor(a) principal: Santos,Guida
Data de Publicação: 2013
Outros Autores: Sousa,Lourdes Emerenciano, João,Alexandre Miguel Bruno Lopes
Tipo de documento: Relatório
Idioma: eng
Título da fonte: Anais brasileiros de dermatologia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962013000800026
Resumo: The paradoxical adverse effects of tumor necrosis factor-alpha (TNF-alpha) antagonists have been described frequently as a result of the widespread use of these drugs. Among the TNF-alpha blocking agents, few reports exist relating the use of adalimumab in cutaneous sarcoidosis, although all of them show good results. More recently, sarcoidosis onsets have been reported with various TNF-alpha inhibitors. The current case is, to our knowledge, the first to describe the exacerbation of cutaneous lesions of sarcoidosis treated with adalimumab.
id SBD-1_327b396c2ce0d9fc4c295b1b10aae53e
oai_identifier_str oai:scielo:S0365-05962013000800026
network_acronym_str SBD-1
network_name_str Anais brasileiros de dermatologia (Online)
repository_id_str
spelling Exacerbation of recalcitrant cutaneous sarcoidosis with adalimumab - a paradoxical effect? A case reportBiological agentsBiological treatmentSarcoidosisTumor necrosis factor-alphaThe paradoxical adverse effects of tumor necrosis factor-alpha (TNF-alpha) antagonists have been described frequently as a result of the widespread use of these drugs. Among the TNF-alpha blocking agents, few reports exist relating the use of adalimumab in cutaneous sarcoidosis, although all of them show good results. More recently, sarcoidosis onsets have been reported with various TNF-alpha inhibitors. The current case is, to our knowledge, the first to describe the exacerbation of cutaneous lesions of sarcoidosis treated with adalimumab.Sociedade Brasileira de Dermatologia2013-12-01info:eu-repo/semantics/reportinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962013000800026Anais Brasileiros de Dermatologia v.88 n.6 suppl.1 2013reponame:Anais brasileiros de dermatologia (Online)instname:Sociedade Brasileira de Dermatologia (SBD)instacron:SBD10.1590/abd1806-4841.20132487info:eu-repo/semantics/openAccessSantos,GuidaSousa,Lourdes EmerencianoJoão,Alexandre Miguel Bruno Lopeseng2014-06-16T00:00:00Zoai:scielo:S0365-05962013000800026Revistahttp://www.anaisdedermatologia.org.br/https://old.scielo.br/oai/scielo-oai.phpabd@sbd.org.br||revista@sbd.org.br1806-48410365-0596opendoar:2014-06-16T00:00Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)false
dc.title.none.fl_str_mv Exacerbation of recalcitrant cutaneous sarcoidosis with adalimumab - a paradoxical effect? A case report
title Exacerbation of recalcitrant cutaneous sarcoidosis with adalimumab - a paradoxical effect? A case report
spellingShingle Exacerbation of recalcitrant cutaneous sarcoidosis with adalimumab - a paradoxical effect? A case report
Santos,Guida
Biological agents
Biological treatment
Sarcoidosis
Tumor necrosis factor-alpha
title_short Exacerbation of recalcitrant cutaneous sarcoidosis with adalimumab - a paradoxical effect? A case report
title_full Exacerbation of recalcitrant cutaneous sarcoidosis with adalimumab - a paradoxical effect? A case report
title_fullStr Exacerbation of recalcitrant cutaneous sarcoidosis with adalimumab - a paradoxical effect? A case report
title_full_unstemmed Exacerbation of recalcitrant cutaneous sarcoidosis with adalimumab - a paradoxical effect? A case report
title_sort Exacerbation of recalcitrant cutaneous sarcoidosis with adalimumab - a paradoxical effect? A case report
author Santos,Guida
author_facet Santos,Guida
Sousa,Lourdes Emerenciano
João,Alexandre Miguel Bruno Lopes
author_role author
author2 Sousa,Lourdes Emerenciano
João,Alexandre Miguel Bruno Lopes
author2_role author
author
dc.contributor.author.fl_str_mv Santos,Guida
Sousa,Lourdes Emerenciano
João,Alexandre Miguel Bruno Lopes
dc.subject.por.fl_str_mv Biological agents
Biological treatment
Sarcoidosis
Tumor necrosis factor-alpha
topic Biological agents
Biological treatment
Sarcoidosis
Tumor necrosis factor-alpha
description The paradoxical adverse effects of tumor necrosis factor-alpha (TNF-alpha) antagonists have been described frequently as a result of the widespread use of these drugs. Among the TNF-alpha blocking agents, few reports exist relating the use of adalimumab in cutaneous sarcoidosis, although all of them show good results. More recently, sarcoidosis onsets have been reported with various TNF-alpha inhibitors. The current case is, to our knowledge, the first to describe the exacerbation of cutaneous lesions of sarcoidosis treated with adalimumab.
publishDate 2013
dc.date.none.fl_str_mv 2013-12-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/report
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format report
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962013000800026
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962013000800026
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/abd1806-4841.20132487
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Dermatologia
publisher.none.fl_str_mv Sociedade Brasileira de Dermatologia
dc.source.none.fl_str_mv Anais Brasileiros de Dermatologia v.88 n.6 suppl.1 2013
reponame:Anais brasileiros de dermatologia (Online)
instname:Sociedade Brasileira de Dermatologia (SBD)
instacron:SBD
instname_str Sociedade Brasileira de Dermatologia (SBD)
instacron_str SBD
institution SBD
reponame_str Anais brasileiros de dermatologia (Online)
collection Anais brasileiros de dermatologia (Online)
repository.name.fl_str_mv Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)
repository.mail.fl_str_mv abd@sbd.org.br||revista@sbd.org.br
_version_ 1752126419115180032

Registros relacionados